Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis

Shoichi Kuramitsu(Kokura Memorial Hospital), Tomohiro Shinozaki(Department of Health), Masanobu Ohya(Kurashiki Central Hospital), Kenji Andò(Kokura Memorial Hospital), Gaku Nakazawa(Kindai University), Hiroki Shiomi(Kyoto University), Kazushige Kadota(Kurashiki Central Hospital), Futoshi Yamanaka(Shonan Kamakura General Hospital), Kazunori Horie(Sendai Kousei Hospital), Masahiro Natsuaki(Saga University), Takeshi Kimura(Kyoto University), Shigeru Saito(Shonan Kamakura General Hospital), Hiromasa Otake(Kobe University), Hiroyoshi Kawamoto(New Tokyo Hospital)
Circulation Cardiovascular Interventions
June 1, 2019
10.1161/circinterventions.119.007822
Cited by 56

Related Papers

Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography Studies
|Journal of the American College of Cardiology|2012|1.8k
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|830
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|345
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
|Thrombosis and Haemostasis|2020|334
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|296